NANOCELA Trademark

Trademark Overview

On Friday, May 6, 2022, a trademark application was filed for NANOCELA with the United States Patent and Trademark Office. The USPTO has given the NANOCELA trademark a serial number of 97398040. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, October 10, 2024. This trademark is owned by Sun Pharmaceutical Industries Limited. The NANOCELA trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals
nanocela

General Information

Serial Number97398040
Word MarkNANOCELA
Filing DateFriday, May 6, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSun Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN
Party NameSun Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Trademark Events

Event DateEvent Description
Tuesday, May 10, 2022NEW APPLICATION ENTERED
Friday, September 23, 2022ASSIGNED TO EXAMINER
Tuesday, May 10, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 3, 2023PETITION TO REVIVE-GRANTED
Friday, August 4, 2023ASSIGNED TO EXAMINER
Friday, August 4, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, June 27, 2023NOTICE OF ALLOWANCE CANCELLED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, August 3, 2023TEAS PETITION TO REVIVE RECEIVED
Friday, August 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 25, 2023NEW NOA TO ISSUE
Tuesday, October 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 27, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 27, 2024SOU EXTENSION 1 FILED
Wednesday, March 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2024SOU EXTENSION 2 FILED
Thursday, October 10, 2024SOU EXTENSION 2 GRANTED
Thursday, March 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

nanocela delivery facilitate pharmaceuticals compounds consisting agents drug